I saw this and wanted to know if it might be credible...http://blogs.scientificamerican.com/talking-back/2015/04/20/could-a-non-prescription-antifungal-become-a-major-advance-for-multiple-sclerosis/
The use of readily available small molecules to enhance remyelination is very credible and a major area of investigation by pharmaceutical companies and academic researchers. However, none have been demonstrated to perform this function in people with MS as of now.
Revere (Rip) Kinkel MD
Director of the Multiple Sclerosis Program
Professor of Clinical Neurosciences
University of California San Diego